| Bioactivity | DT-3 is a membrane-permeable protein kinase G Iα inhibitory peptide. DT-3 is a guanylyl cyclase? inhibitor and shows pharmacological blockade of the cGMP–PKG signalling[1]. |
| Name | DT-3 |
| CAS | 329306-46-9 |
| Sequence | Arg-Gln-Ile-Lys-Ile-Trp-Phe-Gln-Asn-Arg-Arg-Met-Lys-Trp-Lys-Lys-Leu-Arg-Lys-Lys-Lys-Lys-Lys-His |
| Shortening | RQIKIWFQNRRMKWKKLRKKKKKH |
| Formula | C152H258N52O28S |
| Molar Mass | 3294.07 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Shinichi Takahashi, et al. Nitric oxide-cGMP-protein kinase G pathway negatively regulates vascular transient receptor potential channel TRPC6. J Physiol. 2008 Sep 1;586(17):4209-23. |
DT-3
CAS: 329306-46-9 F: C152H258N52O28S W: 3294.07
DT-3 is a membrane-permeable protein kinase G Iα inhibitory peptide. DT-3 is a guanylyl cyclase? inhibitor and shows ph
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.